Delivery Order SPE2DB22D1202-SPE2DB24FUWR3
- Not listed
- This federal contract award, valued at $1,516.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of Ciproflox-Dexameth Otic Suspension, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of August 22, 2024. This delivery order award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $15,563.22 Firm Fixed Price delivery order is for the supply of 4558599936 units of the pharmaceutical product Ciproflox-Dexameth Otic Suspension 7.5ML. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical to provide a...
- This federal contract award, valued at $1,068.75, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is a delivery order for the supply of 4561759442 CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, with a completion date of August 11, 2023. This award is not designated as a set-aside contract. AmerisourceBergen Corporation, one of the largest pharmaceutical distribution...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,125.77 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $8,641.44, is for the delivery of Ciprofloxacin-Dexamethasone Otic Suspension, a pharmaceutical product used to treat certain ear infections. This is a firm fixed-price delivery order contract with a completion date of July 23, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a major...
- This federal contract award from the Defense Logistics Agency (DLA) is a $3,212.62 Firm Fixed Price Delivery Order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, with a period of performance through October 30, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,755.52, is for the delivery of Ciproflox-Dexameth Otic Suspension, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a completion date of February 22, 2023. The contract was not set aside for any specific business type. Amerisourcebergen holds a $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,005.20 firm fixed-price delivery order is for the medical product "CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML" and has an ultimate completion date of October 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,910.59, is for the delivery of the pharmaceutical product Ciproflox-Dexameth Otic Suspension 7.5 ML. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 24, 2023. This award is not designated as a set-aside contract. AmerisourceBergen...
- This federal contract award, valued at $1,296.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ciproflox-Dexameth Otic Suspension, a medical product used for various pharmaceutical applications. The contract has a completion date of July 3, 2024 and is structured as a firm fixed-price delivery order. There is no set-aside designation, indicating the contract was awarded through open...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUWR3Delivery Order
This federal contract award, valued at $2,582.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is a firm fixed price delivery order for the pharmaceutical product Ciproflox-Dexameth Otic Suspension 7.5ML, with a completion date of April 12, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order falls under that broader IDC. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 4/11/24 |